Obalon Therapeutics, Inc. Announces Resignation of David Moatazedi as Member of the Board, the Compensation Committee, and the Audit Committee

On June 30, 2020, David Moatazedi, informed the Board of Directors of Obalon Therapeutics, Inc. of his decision to resign, effective immediately, as a member of the Board, the Compensation Committee, and the Audit Committee.